Cargando…
Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment
BACKGROUND: Pulmonary side effects are well known, including lung fibrosis, in elderly patients treated with long-term nitrofurantoin to prevent urinary tract infections and secondary renal injury. However, pulmonary side effects have only been reported rarely in paediatric cases, despite nitrofuran...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689986/ https://www.ncbi.nlm.nih.gov/pubmed/33243181 http://dx.doi.org/10.1186/s12890-020-01353-x |
_version_ | 1783613976018419712 |
---|---|
author | Mikkelsen, Lise Fischer Rubak, Sune |
author_facet | Mikkelsen, Lise Fischer Rubak, Sune |
author_sort | Mikkelsen, Lise Fischer |
collection | PubMed |
description | BACKGROUND: Pulmonary side effects are well known, including lung fibrosis, in elderly patients treated with long-term nitrofurantoin to prevent urinary tract infections and secondary renal injury. However, pulmonary side effects have only been reported rarely in paediatric cases, despite nitrofurantoin being a first line prophylactic treatment of recurrent childhood urinary tract infection. CASE PRESENTATIONS: A 6-year-old girl was admitted to the hospital with dyspnea, general fatigue, loss of appetite and need for nasal oxygen treatment after long-term nitrofurantoin treatment. A computed tomography scan of the chest showed lung fibrosis. A biopsy confirmed this diagnosis. We suspected the fibrosis to be caused by the nitrofurantoin treatment. Thorough examinations reveal no other explanations. Nitrofurantoin was discontinued and the girl was treated with methylprednisolone. After 17 month a new scan and lung function test showed total regression of the lung fibrosis. CONCLUSIONS: This case underlines that risk of severe side effects should be taken in to account before initiation of long-term nitrofurantoin treatment in children. |
format | Online Article Text |
id | pubmed-7689986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76899862020-11-30 Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment Mikkelsen, Lise Fischer Rubak, Sune BMC Pulm Med Case Report BACKGROUND: Pulmonary side effects are well known, including lung fibrosis, in elderly patients treated with long-term nitrofurantoin to prevent urinary tract infections and secondary renal injury. However, pulmonary side effects have only been reported rarely in paediatric cases, despite nitrofurantoin being a first line prophylactic treatment of recurrent childhood urinary tract infection. CASE PRESENTATIONS: A 6-year-old girl was admitted to the hospital with dyspnea, general fatigue, loss of appetite and need for nasal oxygen treatment after long-term nitrofurantoin treatment. A computed tomography scan of the chest showed lung fibrosis. A biopsy confirmed this diagnosis. We suspected the fibrosis to be caused by the nitrofurantoin treatment. Thorough examinations reveal no other explanations. Nitrofurantoin was discontinued and the girl was treated with methylprednisolone. After 17 month a new scan and lung function test showed total regression of the lung fibrosis. CONCLUSIONS: This case underlines that risk of severe side effects should be taken in to account before initiation of long-term nitrofurantoin treatment in children. BioMed Central 2020-11-26 /pmc/articles/PMC7689986/ /pubmed/33243181 http://dx.doi.org/10.1186/s12890-020-01353-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Mikkelsen, Lise Fischer Rubak, Sune Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title | Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title_full | Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title_fullStr | Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title_full_unstemmed | Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title_short | Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
title_sort | reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689986/ https://www.ncbi.nlm.nih.gov/pubmed/33243181 http://dx.doi.org/10.1186/s12890-020-01353-x |
work_keys_str_mv | AT mikkelsenlisefischer reversiblelungfibrosisina6yearoldgirlafterlongtermnitrofurantointreatment AT rubaksune reversiblelungfibrosisina6yearoldgirlafterlongtermnitrofurantointreatment |